DOI QR코드

DOI QR Code

Early Diagnosis and Treatment Strategies of Obesity Hypoventilation Syndrome

비만성 저환기 증후군의 조기 진단 및 치료 전략

  • Hwan Hee Kim (Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Sang Haak Lee (Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Sei Won Kim (Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • 김환희 (은평성모병원 호흡기내과, 가톨릭대학교 의과대학 내과학교실) ;
  • 이상학 (은평성모병원 호흡기내과, 가톨릭대학교 의과대학 내과학교실) ;
  • 김세원 (은평성모병원 호흡기내과, 가톨릭대학교 의과대학 내과학교실)
  • Received : 2022.06.15
  • Accepted : 2022.06.29
  • Published : 2022.06.30

Abstract

Obesity hypoventilation syndrome (OHS) is defined as the triad of obesity (body mass index, [BMI] ≥ 30 kg/m2), daytime hypercapnia (PaCO2 ≥ 45 mm Hg), and sleep breathing disorder, after excluding other causes for hypoventilation. As the obese population increases worldwide, the prevalence of OHS is also on the rise. Patients with OHS have poor quality of life, high risk of frequent hospitalization and increased cardiopulmonary mortality. However, most patients with OHS remain undiagnosed and untreated. The diagnosis typically occurs during the 5th and 6th decades of life and frequently first diagnosed in emergency rooms as a result of acute-on-chronic hypercapnic respiratory failure. Due to the high mortality rate in patients with OHS who do not receive treatment or have developed respiratory failure, early recognition and effective treatment is essential for improving outcomes. Positive airway pressure (PAP) therapy including continuous PAP (CPAP) or noninvasive ventilation (NIV) is the primary management option for OHS. Changes in lifestyle, rehabilitation program, weight loss and bariatric surgery should be also considered.

Keywords

References

  1. Akashiba T, Akahoshi T, Kawahara S, Uematsu A, Katsura K, Sakurai S, et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study. Intern Med 2006;45:1121-1125. https://doi.org/10.2169/internalmedicine.45.1747
  2. Anttalainen U, Saaresranta T, Vahlberg T, Polo O. Short-term medroxyprogesterone acetate in postmenopausal women with sleep-disordered breathing: a placebo-controlled, randomized, double-blind, parallel-group study. Menopause 2014;21:361-368. https://doi.org/10.1097/gme.0000000000000130
  3. Arellano-Maric MP, Hamm C, Duiverman ML, Schwarz S, Callegari J, Storre JH, et al. Obesity hypoventilation syndrome treated with non-invasive ventilation: is a switch to CPAP therapy feasible? Respirology 2020;25:435-442. https://doi.org/10.1111/resp.13704
  4. BaHammam AS. Prevalence, clinical characteristics, and predictors of obesity hypoventilation syndrome in a large sample of Saudi patients with obstructive sleep apnea. Saudi Med J 2015;36:181-189. https://doi.org/10.15537/smj.2015.2.9991
  5. Basoglu OK, Tasbakan MS. Comparison of clinical characteristics in patients with obesity hypoventilation syndrome and obese obstructive sleep apnea syndrome: a case-control study. Clin Respir J 2014;8:167-174. https://doi.org/10.1111/crj.12054
  6. Bingol Z, Pihtili A, Cagatay P, Okumus G, Kiyan E. Clinical predictors of obesity hypoventilation syndrome in obese subjects with obstructive sleep apnea. Respir Care 2015;60:666-672. https://doi.org/10.4187/respcare.03733
  7. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014;149:275-287. https://doi.org/10.1001/jamasurg.2013.3654
  8. Duarte AG, Justino E, Bigler T, Grady J. Outcomes of morbidly obese patients requiring mechanical ventilation for acute respiratory failure. Crit Care Med 2007;35:732-737. https://doi.org/10.1097/01.CCM.0000256842.39767.41
  9. Egea-Santaolalla C, Javaheri S. Obesity hypoventilation syndrome. Current Sleep Medicine Reports 2016;2:12-19. https://doi.org/10.1007/s40675-016-0035-2
  10. Harada Y, Chihara Y, Azuma M, Murase K, Toyama Y, Yoshimura C, et al. Obesity hypoventilation syndrome in Japan and independent determinants of arterial carbon dioxide levels. Respirology 2014;19:1233-1240. https://doi.org/10.1111/resp.12367
  11. Heinemann F, Budweiser S, Dobroschke J, Pfeifer M. Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir Med 2007;101:1229-1235. https://doi.org/10.1016/j.rmed.2006.10.027
  12. Kakazu MT, Soghier I, Afshar M, Brozek JL, Wilson KC, Masa JF, et al. Weight Loss Interventions as treatment of obesity hypoventilation syndrome. A systematic review. Ann Am Thorac Soc 2020;17:492-502. https://doi.org/10.1513/AnnalsATS.201907-554OC
  13. Kauppert CA, Dvorak I, Kollert F, Heinemann F, Jorres RA, Pfeifer M, et al. Pulmonary hypertension in obesity-hypoventilation syndrome. Respir Med 2013;107:2061-2070. https://doi.org/10.1016/j.rmed.2013.09.017
  14. Lee WY, Mokhlesi B. Diagnosis and management of obesity hypoventilation syndrome in the ICU. Crit Care Clin 2008;24:533-549, vii. https://doi.org/10.1016/j.ccc.2008.02.003
  15. Lemyze M, Taufour P, Duhamel A, Temime J, Nigeon O, Vangrunderbeeck N, et al. Determinants of noninvasive ventilation success or failure in morbidly obese patients in acute respiratory failure. PLoS One 2014;9:e97563
  16. Mandal S, Suh ES, Harding R, Vaughan-France A, Ramsay M, Connolly B, et al. Nutrition and Exercise Rehabilitation in Obesity hypoventilation syndrome (NERO): a pilot randomised controlled trial. Thorax 2018;73:62-69. https://doi.org/10.1136/thoraxjnl-2016-209826
  17. Marik PE, Desai H. Characteristics of patients with the "malignant obesity hypoventilation syndrome" admitted to an ICU. J Intensive Care Med 2013;28:124-130. https://doi.org/10.1177/0885066612444261
  18. Masa JF, Benitez I, Sanchez-Quiroga M, Gomez de Terreros FJ, Corral J, Romero A, et al. Long-term noninvasive ventilation in obesity hypoventilation syndrome without severe OSA: the pickwick randomized controlled trial. Chest 2020;158:1176-1186. https://doi.org/10.1016/j.chest.2020.03.068
  19. Masa JF, Corral J, Alonso ML, Ordax E, Troncoso MF, Gonzalez M, et al. Efficacy of different treatment alternatives for obesity hypoventilation syndrome pickwick study. Am J Respir Crit Care Med 2015;192:86-95. https://doi.org/10.1164/rccm.201410-1900OC
  20. Masa JF, Mokhlesi B, Benitez I, Gomez de Terreros FJ, SanchezQuiroga M, Romero A, et al. Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial. Lancet 2019;393:1721-1732. https://doi.org/10.1016/S0140-6736(18)32978-7
  21. Masa JF, Mokhlesi B, Benitez I, Gomez de Terreros Caro FJ, Sanchez-Quiroga M, Romero A, et al. Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea. Thorax 2020;75:459-467. https://doi.org/10.1136/thoraxjnl-2019-213622
  22. Masa JF, Pepin JL, Borel JC, Mokhlesi B, Murphy PB, Sanchez-Quiroga M. Obesity hypoventilation syndrome. Eur Respir Rev 2019;28.
  23. Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc 2008;5:218-225. https://doi.org/10.1513/pats.200708-122MG
  24. Mokhlesi B, Masa JF, Afshar M, Almadana Pacheco V, Berlowitz DJ, Borel JC, et al. The effect of hospital discharge with empiric noninvasive ventilation on mortality in hospitalized patients with obesity hypoventilation syndrome. An individual patient data meta-analysis. Ann Am Thorac Soc 2020;17:627-637. https://doi.org/10.1513/annalsats.201912-887oc
  25. Mokhlesi B, Masa JF, Brozek JL, Gurubhagavatula I, Murphy PB, Piper AJ, et al. Evaluation and management of obesity hypoventilation syndrome. An official american thoracic society clinical practice guideline. Am J Respir Crit Care Med 2019;200:e6-e24. https://doi.org/10.1164/rccm.201905-1071ST
  26. Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care 2010;55:1347-1362; discussion 1363-1345.
  27. Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007;11:117-124. https://doi.org/10.1007/s11325-006-0092-8
  28. Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004;116:1-7. https://doi.org/10.1016/j.amjmed.2004.02.004
  29. Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med 2005;118:948-956.
  30. Palm A, Midgren B, Janson C, Lindberg E. Gender differences in patients starting long-term home mechanical ventilation due to obesity hypoventilation syndrome. Respir Med 2016;110:73-78. https://doi.org/10.1016/j.rmed.2015.11.010
  31. Pierce AM, Brown LK. Obesity hypoventilation syndrome: current theories of pathogenesis. Curr Opin Pulm Med 2015;21:557-562. https://doi.org/10.1097/MCP.0000000000000210
  32. Povitz M, James MT, Pendharkar SR, Raneri J, Hanly PJ, Tsai WH. Prevalence of sleep-disordered breathing in obese patients with chronic hypoxemia. A cross-sectional study. Ann Am Thorac Soc 2015;12:921-927. https://doi.org/10.1513/AnnalsATS.201412-551OC
  33. Ramirez Molina VR, Masa Jimenez JF, Gomez de Terreros Caro FJ, Corral Penafiel J. Effectiveness of different treatments in obesity hypoventilation syndrome. Pulmonology 2020;26:370-377. https://doi.org/10.1016/j.pulmoe.2020.05.012
  34. Rapoport DM, Garay SM, Epstein H, Goldring RM. Hypercapnia in the obstructive sleep apnea syndrome. A reevaluation of the "Pickwickian syndrome". Chest 1986;89:627-635. https://doi.org/10.1378/chest.89.5.627
  35. Raurich JM, Rialp G, Ibanez J, Llompart-Pou JA, Ayestaran I. Hypercapnic respiratory failure in obesity-hypoventilation syndrome: CO2 response and acetazolamide treatment effects. Respir Care 2010;55:1442-1448.